Meda has a well-diversified product portfolio, a global presence, and is represented within several therapy areas. Prescription drugs account for around 73% of sales while OTC drugs account for 24%.
Meda's products fall within several therapy areas but the main focus is respiratory and dermatology. In 2013, products in these two therapy areas accounted for 42% of total sales.
For additional information about Meda's products and their availability see each country's local website.